Regulating macrophage-MSC interaction to optimize BMP-2-induced osteogenesis in the local microenvironment

Area of Science:

• * Regenerative Medicine
• * Immunology
• * Orthopedics

Background:

• * Bone morphogenetic protein-2 (BMP-2) is FDA-approved for bone regeneration but has variable efficacy and dose-dependent side effects.
• * Osteoimmunomodulation, the interplay between bone formation and the immune system, is crucial for growth factor-based bone regeneration.
• * Proinflammatory signals can significantly influence the osteogenic potential of BMP-2.

Purpose of the Study:

• * To investigate how proinflammatory signals affect the dose-dependent osteogenic potential of BMP-2.
• * To elucidate the role of macrophage-mesenchymal stem cell (MSC) interactions in BMP-2-induced osteogenesis.
• * To explore strategies for optimizing BMP-2 dosage through immunomodulation.

Main Methods:

• * Mouse osteogenesis model to assess BMP-2's effect on bone formation and local cytokine expression.
• * Analysis of macrophage polarization (M1) and MSC response to varying BMP-2 doses.
• * Investigation of the role of IL-1β and IL-1 receptor antagonist (IL-1Ra) in the local microenvironment.
• * Evaluation of anti-inflammatory drug (Dexamethasone) effects on osteogenesis and immune cell behavior.

Main Results:

• * Local IL-1β expression did not consistently increase with BMP-2 dose.
• * Low BMP-2 doses triggered IL-1β release from M1 macrophages without promoting bone formation.
• * Higher BMP-2 doses inhibited M1 infiltration and IL-1β expression, with MSCs releasing IL-1Ra, leading to new bone formation.
• * Dexamethasone enhanced BMP-2-induced osteogenesis by suppressing M1 polarization and promoting MSC differentiation.

Conclusions:

• * The osteogenic effect of BMP-2 is mediated by macrophage-MSC interactions influenced by BMP-2 dosage.
• * IL-1 receptor 1 (IL-1R1) ligands, including IL-1β and IL-1Ra, are central to this interaction.
• * Immunoregulatory strategies targeting macrophage-MSC crosstalk can potentially reduce the required BMP-2 dose for effective bone regeneration.